Meet the team: Gemma Little
Some of the best research comes from the sharing of ideas, skills and experiences. Between scientists, between facilities – and between countries.
HRI presents at ISTH 2019
HRI was strongly represented at the recent International Society on Thrombosis and Haemostasis (ISTH) Congress.
HRI welcomes Dr Xuyu Liu
HRI is pleased to welcome Dr Xuyu (John) Liu as Unit Leader.
Top HRI scientist takes exciting next step
Talented Heart Research Institute (HRI) bioengineer Dr Steven Wise is taking up an exciting opportunity to further his innovative research program with the HRI’s close collaborative partner The University of Sydney (USYD).
Mentoring the next generation of scientists
Recently, ten bright young researchers from New Zealand took part in a summer scholarship at the HRI to get hands-on experience in our world-class laboratory facilities and to be mentored by leaders in the cardiovascular disease research field. They share their experiences here.
HRI awarded at ASMR meeting
Congratulations to Manisha Patil, Bob Lee and Dr Richard Tan on receiving awards at the Australian Society for Medical Research (ASMR) Annual Scientific Meeting on Friday 31 May.
HRI speaks to Channel 7 News
Preeclampsia (high blood pressure during pregnancy) is the leading cause of stillbirths and newborn deaths in Australia. It also doubles a woman’s risk of heart disease and stroke later in life.
HRI's Professor Annemarie Hennessy talks to Channel 7 News about preeclampsia.
Nano ‘junk’ could save lives
Scientists at the Heart Research Institute in Sydney have developed a simple, cheap and efficient way to collect nanoparticles that can be used in the treatment of cancer, cardiovascular disease and Alzheimer’s.
HRI calls on Aussies to support mums-to-be
In Australia, cardiovascular disease continues to take the lives of 22 females every day – killing almost three times more women than breast cancer. Preeclampsia and gestational diabetes developed during pregnancy can significantly increase a woman’s risk of heart disease later in life, but these can be manageable complications if monitored.